Navigation Links
Bacchus Vascular Names Scott Cramer as President and CEO

Experienced Sales Executive to Lead Growing Medical Device Firm

SANTA CLARA, Calif., Oct. 16 /PRNewswire/ -- Bacchus Vascular Inc., a leading provider of innovative medical devices used by interventional radiologists and vascular surgeons for the minimally invasive treatment of deep vein thrombosis (DVT) and other peripheral vascular disease, announced today that it has named Scott Cramer to the position of President and Chief Executive Officer.

Mr. Cramer joined Bacchus Vascular earlier this year as Senior Vice President of Sales. Previously he served as Senior Vice President of U.S. Sales and Account Services for VNUS Medical Technologies (Nasdaq: VNUS) from 2000 until April, 2007. Prior to that, Mr. Cramer held senior management positions with EndoSonics Corporation and Cardiometrics, Inc., as well as management positions with Baxter Healthcare Corporation's cardiovascular division. Mr. Cramer holds a B.S. degree in Finance from the Philadelphia University.

"Scott Cramer has a broad background in the vascular disease and interventional field, a strong track record of introducing innovative medical technologies, and proven success developing new markets," said Elizabeth H. (Bess) Weatherman, Managing Director, Healthcare - Medical Devices for Warburg Pincus LLC, and a Director of Bacchus Vascular.

"Scott brings a wealth of experience to Bacchus Vascular, and we look forward to his leadership in the next phase of the Company's growth," added Thomas Fogarty, MD, Chairman of the Board of Bacchus Vascular.

The Company's previous President and CEO, R. Scott Rader, is relocating to the east coast to fulfill family obligations and pursue other business opportunities. He will remain on the Board of Directors of Bacchus Vascular.

"Scott Rader successfully led Bacchus Vascular through three years of product development, market introduction and clinical success with the Trellis device. We are grateful for his skilled leadership during this stage of the Company's development and are pleased that he will be remaining on the Board of Directors," said Dr. Fogarty.

About Bacchus Vascular

Bacchus Vascular, Inc. is a privately-held medical device company dedicated to the treatment of peripheral vascular disease. Dr. Thomas Fogarty, a noted inventor and cardiovascular surgeon, founded the company with the vision of transforming blood clot removal from peripheral blood vessels into a fast, simple, minimally-invasive catheter-based procedure. Thousands of patients suffering from DVT and other occlusive vascular diseases have been treated worldwide to date using the company's Trellis(R) Peripheral Infusion System and other products.

For more information, visit

SOURCE Bacchus Vascular Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. “Don’t fear long haul flights!” Vascular surgeon tells travelrs
2. People who fight wars may be at high risk of cardiovascular disease
3. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
4. High iron levels may cause Cardiovascular Disease in women
5. Erectile dysfunction (ED) signals vascular disease
6. Drug Effective for Vascular Dementia
7. Air Pollution said To Increase Risk of Cardiovascular Disease
8. Link Between Alcohol Consumption And Cardiovascular Disease
9. Beer Found To Be Effective In Fighting Cardiovascular Disease
10. New Guidelines Found To Benefit Cardiovascular Treatment
11. Women With A High-Risk Of Cardiovascular Disease Under treated
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in ... ways they remain in the eye of the beholder, according to experts who offered ... The American Journal of Managed Care. For the full issue, click here . ...
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Story Highlights: ... the health care industry is causing providers to review ... Deloitte offers a suite of solutions for health care ... cost optimization: labor resource analysis, revenue cycle optimization and ... outcomes and better economics ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 24, 2016 Research and ... "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" report ... In-Mold Electronics, Smart Skin, Structural Health Monitoring, ... Structural electronics involves electronic and/or electrical components ... replacing dumb structures such as vehicle bodies or ...
Breaking Medicine Technology: